Cargando…
Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey
BACKGROUND: Migraine is a primary headache disorder characterized by recurrent attacks that may have a significant impact on patients’ daily life. Treatment options must often be re-evaluated in light of efficacy, tolerability and compliance issues. Few data on commonly applied treatment algorithms...
Autores principales: | Koch, M., Katsarava, Z., Baufeld, C., Schuh, K., Gendolla, A., Straube, A., von Pannwitz, W., Hofmann, W. E., Ortler, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428142/ https://www.ncbi.nlm.nih.gov/pubmed/34503443 http://dx.doi.org/10.1186/s10194-021-01316-5 |
Ejemplares similares
-
Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
por: Straube, Andreas, et al.
Publicado: (2021) -
Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study
por: Gendolla, Astrid, et al.
Publicado: (2021) -
Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020) -
Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study
por: Porst, Michael, et al.
Publicado: (2020) -
Migraine and tension type headache in adolescents at grammar school in Germany – burden of disease and health care utilization
por: Albers, Lucia, et al.
Publicado: (2015)